Dyne Therapeutics, Inc. (DYN)
17.77
-0.49
(-2.68%)
USD |
NASDAQ |
Jan 09, 16:00
17.78
+0.01
(+0.06%)
Pre-Market: 09:14
Dyne Therapeutics Accounts Payable (Quarterly): 12.06M for Sept. 30, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Avidity Biosciences, Inc. | 9.626M |
| MannKind Corp. | 7.269M |
| Sarepta Therapeutics, Inc. | 94.02M |
| Denali Therapeutics, Inc. | 6.745M |
| Kymera Therapeutics, Inc. | 5.506M |